Merck Serono, Ablynx expands Nanobodies research patnership

Merck Serono, Ablynx expand Nanobodies research patnership

11:10 AM, 27th September 2013
Merck Serono, Ablynx business news

GHENT, BELGIUM: Merck Serono, the biopharmaceutical division of Merck KGaA, and Ablynx have further expanded their relationship through a multi-year research alliance that could lead to at least four co-discovery and co-development collaborations. Both partners will jointly select disease targets against which this group will develop Nanobodies, up to in vivo proof-of-principle. The dedicated group will focus on the discovery and development of Nanobodies against a number of targets across multiple disease areas. The collaboration will span all of Merck Serono’s core research and development fields, including oncology, immuno-oncology, immunology and neurology.

“This is a very exciting expansion of our partnership with Merck Serono, building on the success of our existing collaborations and allowing us to exploit the broad and powerful applicability of our Nanobody platform with a partner with whom we have successfully worked for over five years. The new alliance is an early stage discovery initiative, which allows the companies to rapidly explore the potential of novel targets across a range of therapeutic areas and to determine which programme should be prioritised for later stage development. It is a very interesting model that could create substantial value for both parties and one which we believe could be applicable for us in other partnerships,” said Dr Edwin Moses, Chairman and CEO, Ablynx.

 

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Air Products adds new members to the board

LEHIGH VALLEY, US: Air Products will add three new independent directors to its Board of Directors and will commence a search to identify a ...

Read more
Toray to acquire Zoltek for $584 million

TOKYO, JAPAN: Toray Industries Inc has agreed to purchase the entire stake at $16.75 per share (total of $584 million) in Zoltek Companies Inc, engagi ...

Read more
Oxea to expand 3-methylbutanol portfolio

OBERHAUSEN, GERMANY: Chemical manufacturer Oxea is expanding its portfolio of higher alcohols with 3-methylbutanol (isoamyl alcohol), a versatile inte ...

Read more
Clariant opens global headquarters for Oil and Mining in Texas, US

HOUSTON, US: Clariant, a world leader in Specialty Chemicals, opened its new global headquarters for Oil and Mining Services business unit in The Wood ...

Read more
Environmental chemicals highers pregnancy risk, says AP report

WASHINGTON, US: From mercury to pesticides, Americans are exposed daily to environmental chemicals that could harm reproductive health, said the natio ...

Read more
Making cosmetics, sunscreens safer…

WASHINGTON DC, US: Use of a particular type of titanium dioxide, a common ingredient in cosmetics, food products, toothpaste and sunscreen, could redu ...

Read more